Evidence map›Paper›PMID 24872566›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2014

Overexpression of the astrocyte glutamate transporter GLT1 exacerbates phrenic motor neuron degeneration, diaphragm compromise, and forelimb motor dysfunction following cervical contusion spinal cord injury.

Ke Li, Charles Nicaise, Daniel Sannie, Tamara J Hala, Elham Javed, Jessica L Parker, Rajarshi Putatunda, Kathleen A Regan, Valérie Suain, Jean-Pierre Brion and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. USP1/UAF1-Stabilized METTL3 Promotes Reactive Astrogliosis and Improves Functional Recovery after Spinal Cord Injury through mThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Transplantation of M2-Deviated Microglia Promotes Recovery of Motor Function after Spinal Cord Injury in Mice.Molecular therapy : the journal of the American Society of Gene Therapy · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Ke LiDepartment of Neuroscience, Farber Institute for Neurosciences, Thomas Jefferson University Medical College, Philadelphia, Pennsylvania 19107.
Charles NicaiseDepartment of Neuroscience, Farber Institute for Neurosciences, Thomas Jefferson University Medical College, Philadelphia, Pennsylvania 19107, Neurodegeneration and Regeneration Unit, L'Unité de Recherché en Physiologie Moléculaire-Namur Research Institute for Life Sciences, University of Namur, B-5000 Namur, Belgium.
Daniel SannieDepartment of Neuroscience, Farber Institute for Neurosciences, Thomas Jefferson University Medical College, Philadelphia, Pennsylvania 19107.
Tamara J HalaDepartment of Neuroscience, Farber Institute for Neurosciences, Thomas Jefferson University Medical College, Philadelphia, Pennsylvania 19107.ORCID http://orcid.org/0000-0001-5851-271X
Elham JavedDepartment of Neuroscience, Farber Institute for Neurosciences, Thomas Jefferson University Medical College, Philadelphia, Pennsylvania 19107.
Jessica L ParkerDepartment of Neuroscience, Farber Institute for Neurosciences, Thomas Jefferson University Medical College, Philadelphia, Pennsylvania 19107.
Rajarshi PutatundaDepartment of Neuroscience, Farber Institute for Neurosciences, Thomas Jefferson University Medical College, Philadelphia, Pennsylvania 19107.
Kathleen A ReganDepartment of Neuroscience, Farber Institute for Neurosciences, Thomas Jefferson University Medical College, Philadelphia, Pennsylvania 19107.
Valérie SuainLaboratory of Histology, Neuroanatomy and Neuropathology, Université Libre de Bruxelles, B-1070 Brussels, Belgium.
Jean-Pierre BrionLaboratory of Histology, Neuroanatomy and Neuropathology, Université Libre de Bruxelles, B-1070 Brussels, Belgium.
Fred RhoderickDepartment of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, Montana 59812, and.
Megan C WrightDepartment of Biology, Arcadia University, Glenside, Pennsylvania 19038.
David J PoulsenDepartment of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, Montana 59812, and.
Angelo C LeporeDepartment of Neuroscience, Farber Institute for Neurosciences, Thomas Jefferson University Medical College, Philadelphia, Pennsylvania 19107, Angelo.Lepore@jefferson.edu.
Thomas Jefferson University · USUniversité Libre de Bruxelles · BEUniversity of Montana · USArcadia University · US

Funding

Respiratory Motor Neuron Protection Following Cervical Spinal Cord InjuryR01NS079702 · NINDS · THOMAS JEFFERSON UNIVERSITY · PI Angelo C. Lepore · 2013 to 2026
$6.0M
NINDS NIH HHS 1R01NS079702NINDS NIH HHS R01 NS079702
6 · The paper itself

Abstract

A major portion of spinal cord injury (SCI) cases affect midcervical levels, the location of the phrenic motor neuron (PhMN) pool that innervates the diaphragm. While initial trauma is uncontrollable, a valuable opportunity exists in the hours to days following SCI for preventing PhMN loss and consequent respiratory dysfunction that occurs during secondary degeneration. One of the primary causes of secondary injury is excitotoxic cell death due to dysregulation of extracellular glutamate homeostasis. GLT1, mainly expressed by astrocytes, is responsible for the vast majority of functional uptake of extracellular glutamate in the CNS, particularly in spinal cord. We found that, in bacterial artificial chromosome-GLT1-enhanced green fluorescent protein reporter mice following unilateral midcervical (C4) contusion SCI, numbers of GLT1-expressing astrocytes in ventral horn and total intraspinal GLT1 protein expression were reduced soon after injury and the decrease persisted for ≥6 weeks. We used intraspinal delivery of adeno-associated virus type 8 (AAV8)-Gfa2 vector to rat cervical spinal cord ventral horn for targeting focal astrocyte GLT1 overexpression in areas of PhMN loss. Intraspinal delivery of AAV8-Gfa2-GLT1 resulted in transduction primarily of GFAP(+) astrocytes that persisted for ≥6 weeks postinjury, as well as increased intraspinal GLT1 protein expression. Surprisingly, we found that astrocyte-targeted GLT1 overexpression increased lesion size, PhMN loss, phrenic nerve axonal degeneration, and diaphragm neuromuscular junction denervation, and resulted in reduced functional diaphragm innervation as assessed by phrenic nerve-diaphragm compound muscle action potential recordings. These results demonstrate that GLT1 overexpression via intraspinal AAV-Gfa2-GLT1 delivery exacerbates neuronal damage and increases respiratory impairment following cervical SCI.

Indexed as

Cervical VertebraeAnimalsAstrocytesDiaphragmExcitatory Amino Acid Transporter 2FemaleForelimbGene Expression RegulationMaleMiceMice, Inbred C57BLMice, TransgenicMotor NeuronsNerve DegenerationPhrenic NerveRatsExcitatory Amino Acid Transporter 2Slc1a2 protein, mouseadeno-associated virusgene therapyglutamate transporterphrenic motor neuronrespiratoryspinal cord injury

Identifiers

PMID24872566
PMCPMC4035523
OpenAlexW2052930675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.